CY1124354T1 - Εμφυτευσιμη συσκευη με ενδοκυστικη ανεκτικοτητα - Google Patents
Εμφυτευσιμη συσκευη με ενδοκυστικη ανεκτικοτηταInfo
- Publication number
- CY1124354T1 CY1124354T1 CY20211100370T CY211100370T CY1124354T1 CY 1124354 T1 CY1124354 T1 CY 1124354T1 CY 20211100370 T CY20211100370 T CY 20211100370T CY 211100370 T CY211100370 T CY 211100370T CY 1124354 T1 CY1124354 T1 CY 1124354T1
- Authority
- CY
- Cyprus
- Prior art keywords
- bladder
- treatment
- patient
- prescribed
- dimensions
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 210000003708 urethra Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/042—Urinary bladders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28764909P | 2009-12-17 | 2009-12-17 | |
| US32571310P | 2010-04-19 | 2010-04-19 | |
| PCT/US2010/061161 WO2011084712A1 (en) | 2009-12-17 | 2010-12-17 | Implantable device with intravesical tolerability and methods of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124354T1 true CY1124354T1 (el) | 2022-07-22 |
Family
ID=43769298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100370T CY1124354T1 (el) | 2009-12-17 | 2021-04-28 | Εμφυτευσιμη συσκευη με ενδοκυστικη ανεκτικοτητα |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US8679094B2 (enExample) |
| EP (2) | EP2512581B1 (enExample) |
| JP (3) | JP2013514837A (enExample) |
| AU (1) | AU2010339821B2 (enExample) |
| CA (1) | CA2784601C (enExample) |
| CY (1) | CY1124354T1 (enExample) |
| DK (2) | DK2512581T3 (enExample) |
| ES (2) | ES3038403T3 (enExample) |
| FI (1) | FI3884988T3 (enExample) |
| HR (2) | HRP20210329T1 (enExample) |
| HU (1) | HUE053888T2 (enExample) |
| LT (2) | LT3884988T (enExample) |
| PL (2) | PL3884988T3 (enExample) |
| PT (2) | PT3884988T (enExample) |
| RS (2) | RS67130B1 (enExample) |
| SI (2) | SI3884988T1 (enExample) |
| SM (2) | SMT202500293T1 (enExample) |
| WO (1) | WO2011084712A1 (enExample) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
| US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
| US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
| US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
| US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| CA2784601C (en) * | 2009-12-17 | 2016-06-14 | Taris Biomedical, Inc. | Implantable device with intravesical tolerability and methods of treatment |
| US20110218488A1 (en) * | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| US20110308835A1 (en) * | 2010-06-16 | 2011-12-22 | Piekny Mark G | Self-coiling apparatus |
| PT2600800T (pt) | 2010-08-05 | 2020-11-05 | Taris Biomedical Llc | Dispositivo de administração de drogas por stent ureteral, kit e método |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| JP5945544B2 (ja) | 2010-10-06 | 2016-07-05 | タリス バイオメディカル エルエルシー | 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法 |
| US8679093B2 (en) | 2010-11-23 | 2014-03-25 | Microchips, Inc. | Multi-dose drug delivery device and method |
| RU2620032C2 (ru) * | 2011-01-10 | 2017-05-22 | Аллерган, Инк. | Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании |
| CA2825399A1 (en) | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
| US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
| US10610294B2 (en) | 2012-04-22 | 2020-04-07 | Newuro, B.V. | Devices and methods for transurethral bladder partitioning |
| US9883906B2 (en) | 2012-04-22 | 2018-02-06 | Newuro, B.V. | Bladder tissue modification for overactive bladder disorders |
| US9387163B2 (en) * | 2012-04-30 | 2016-07-12 | Allergan, Inc. | Methods for treatment of pelvic pain and/or comorbid conditions |
| BR112014028916B1 (pt) * | 2012-05-19 | 2022-01-11 | Taris Biomedical Llc | Dispositivo médico |
| US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
| PT2890384T (pt) | 2012-08-31 | 2022-01-21 | Taris Biomedical Llc | Sistemas e métodos para administração de fármacos para tratamento de cancro de bexiga contendo oxaliplatina |
| WO2014036556A2 (en) | 2012-08-31 | 2014-03-06 | Taris Biomedical, Inc. | Drug delivery systems and methods for treatment of prostate |
| AU2013318146B2 (en) * | 2012-09-18 | 2018-05-10 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium |
| WO2014138214A1 (en) | 2013-03-05 | 2014-09-12 | Taris Biomedical, Inc. | Drug delivery devices and methods for controlled drug release through device orifice |
| PT2968880T (pt) | 2013-03-15 | 2025-07-07 | Taris Biomedical Llc | Dispositivos de aplicação de fármaco com componente permeável a fármaco |
| MX391755B (es) | 2013-03-15 | 2025-03-21 | Taris Biomedical Llc | Dispositivos de administración de medicamentos y métodos para administración de medicamentos. |
| SMT202000472T1 (it) | 2013-08-19 | 2020-11-10 | Taris Biomedical Llc | Dispositivi di somministrazione di farmaco multi-unità |
| RU2016120199A (ru) | 2013-11-05 | 2017-12-11 | ТАРИС Биомедикал ЛЛК | Осмотические устройства, комплекты и способы для доставки лекарственных средств |
| SI4124339T1 (sl) * | 2014-03-06 | 2025-11-28 | Taris Biomedical Llc | Sistemi za dostavo zdravila in metode za zdravljenje raka mehurja z gemcitabinom |
| JP2017519541A (ja) | 2014-05-12 | 2017-07-20 | タリス バイオメディカル エルエルシー | 薬物送達装置及び方法 |
| EP3160442B1 (en) * | 2014-06-26 | 2019-03-06 | TARIS Biomedical LLC | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| US20170246437A1 (en) | 2014-09-12 | 2017-08-31 | Taris Biomedical Llc | pH-MODULATING DRUG DELIVERY DEVICES AND METHODS |
| ES2734394T3 (es) | 2015-03-30 | 2019-12-05 | Taris Biomedical Llc | Dispositivos para la administración local fármacos al tracto urinario superior |
| GB201505527D0 (en) | 2015-03-31 | 2015-05-13 | Jmedtech Pte Ltd | Composition |
| JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
| US20180199816A1 (en) * | 2015-05-26 | 2018-07-19 | Taris Biomedical Llc | Urodynamic assessment sysrems and methods |
| US10159850B2 (en) * | 2016-01-06 | 2018-12-25 | Covidien Lp | Brachytherapy clip and applicator |
| WO2017132372A1 (en) | 2016-01-26 | 2017-08-03 | Taris Biomedical Llc | Multi-lumen drug delivery devices |
| WO2017151983A1 (en) | 2016-03-02 | 2017-09-08 | Taris Biomedical Llc | Osmotic drug delivery devices and methods of making osmotic drug delivery devices |
| MX389296B (es) | 2016-05-06 | 2025-03-20 | Taris Biomedical Llc | Metodo para tratar cancer urotelial del tracto inferior. |
| US11707611B2 (en) * | 2016-11-08 | 2023-07-25 | W. L. Gore & Associates, Inc. | Implantable apparatus for retention of biological moieties |
| CA3046087A1 (en) | 2016-12-09 | 2018-06-14 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
| ES2873084T3 (es) | 2017-02-01 | 2021-11-03 | Taris Biomedical Llc | Dispositivos para la administración de fármacos in vivo |
| SG10201913998YA (en) | 2017-07-25 | 2020-03-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| JP2020536955A (ja) | 2017-10-06 | 2020-12-17 | ファウンドリー セラピューティクス， インコーポレイテッド | 治療剤の制御放出のための埋込み可能なデポー |
| KR102892737B1 (ko) | 2017-11-08 | 2025-11-28 | 타리스 바이오메디컬 엘엘씨 | 젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법 |
| EP4218632B1 (en) | 2017-12-23 | 2024-10-30 | Teleflex Life Sciences LLC | Expandable tissue engagement apparatus |
| CN116650732A (zh) | 2018-01-08 | 2023-08-29 | 铸造疗法股份有限公司 | 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法 |
| CN112367980A (zh) | 2018-05-12 | 2021-02-12 | 铸造疗法股份有限公司 | 用于控制释放治疗剂的可植入贮库 |
| WO2020028554A1 (en) | 2018-08-01 | 2020-02-06 | Taris Biomedical Llc | Methods of treating overactive bladder using trospium |
| WO2020047013A1 (en) | 2018-08-28 | 2020-03-05 | Foundry Therapeutics, Inc. | Polymer implants |
| US12440301B2 (en) | 2018-11-07 | 2025-10-14 | Teleflex Life Sciences Llc | System for delivery of a fiducial marker |
| TW202333720A (zh) | 2021-10-12 | 2023-09-01 | 美商塔里斯生物醫學有限責任公司 | 用於膀胱內施用的厄達替尼調配物及系統 |
| CA3243565A1 (en) | 2021-12-21 | 2023-06-29 | Taris Biomedical Llc | URINARY PLACEMENT CATHETER FOR INTRAVESICAL DEVICES |
| CA3252554A1 (en) | 2022-02-18 | 2023-08-24 | Taris Biomedical Llc | ERDAFITINIB FORMULATIONS AND OSMOTIC SYSTEMS FOR INTRAVESICAL ADMINISTRATION |
| KR20250021376A (ko) | 2022-06-08 | 2025-02-12 | 브라이트 유로, 아이엔씨. | 비뇨기과적 감지를 위한 시스템 및 방법 |
| US12426818B2 (en) | 2022-06-08 | 2025-09-30 | Bright Uro, Inc. | Packaging assembly and method of preparing sensing device for insertion into a body cavity to preserve sterility |
| EP4536100A1 (en) * | 2022-06-10 | 2025-04-16 | Balt Usa, Llc | Implants and systems for vascular treatment |
| WO2024092159A1 (en) | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
| CN120731076A (zh) | 2023-02-13 | 2025-09-30 | 塔里斯生物医药公司 | 膀胱内施用厄达替尼以用于治疗膀胱癌 |
| CN120731077A (zh) | 2023-02-17 | 2025-09-30 | 塔里斯生物医药公司 | 膀胱内施用厄达替尼以用于治疗膀胱癌 |
| AU2024249710A1 (en) | 2023-04-10 | 2025-11-20 | Taris Biomedical Llc | Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy |
| CN117017567B (zh) * | 2023-08-12 | 2024-04-09 | 上海市第一人民医院 | 一种植入式膀胱收缩系统、工作方法及人造膀胱 |
| WO2025059602A1 (en) | 2023-09-14 | 2025-03-20 | Taris Biomedical Llc | Methods of treating bladder cancer using intravesical administration of erdafitinib |
| TW202532086A (zh) | 2023-10-02 | 2025-08-16 | 美商塔里斯生物醫學有限責任公司 | 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法 |
| GB202401392D0 (en) * | 2024-02-02 | 2024-03-20 | Imphatec Ltd | Implant for delivery of a drug |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4016251A (en) * | 1972-08-17 | 1977-04-05 | Alza Corporation | Vaginal drug dispensing device |
| US3935860A (en) * | 1974-08-21 | 1976-02-03 | Alza Corporation | Intrauterine device with restrictor for maintaining device in uterine cavity |
| US4968507A (en) | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
| US4871542A (en) * | 1987-04-30 | 1989-10-03 | Ferring Service Center, N.V. | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
| GB2206046B (en) * | 1987-06-25 | 1991-04-03 | Alza Corp | Multi-unit delivery system |
| MX9205850A (es) * | 1991-10-10 | 1993-06-01 | Alza Corp | Dispositivos de surtido osmotico de farmaco con materiales de pared hidrofobicos |
| ES2150427T3 (es) | 1992-06-02 | 2000-12-01 | Bard Inc C R | Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo. |
| US5516522A (en) * | 1994-03-14 | 1996-05-14 | Board Of Supervisors Of Louisiana State University | Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same |
| US6171298B1 (en) * | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| WO1998043555A1 (en) * | 1997-04-03 | 1998-10-08 | Point Biomedical Corporation | Intravesical drug delivery system |
| US6749617B1 (en) * | 1997-11-04 | 2004-06-15 | Scimed Life Systems, Inc. | Catheter and implants for the delivery of therapeutic agents to tissues |
| CZ303404B6 (cs) | 1998-02-23 | 2012-08-29 | Massachusetts Institute Of Technology | Kompozice degradovatelného polymeru s tvarovou pametí a predmet z nej vyrobený |
| US6183461B1 (en) * | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| US6159143A (en) * | 1998-06-17 | 2000-12-12 | Scimed Life Systems, Inc. | Method and device for delivery of therapeutic agents in conjunction with isotope seed placement |
| US6293923B1 (en) * | 1999-03-15 | 2001-09-25 | Innoventions, Inc. | Intravesicular balloon |
| US7135311B1 (en) * | 1999-05-05 | 2006-11-14 | Institut Curie | Means for detecting and treating pathologies linked to FGFR3 |
| US6139535A (en) * | 1999-05-27 | 2000-10-31 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
| DE60027458T2 (de) | 1999-12-10 | 2007-07-05 | Massachusetts Institute Of Technology, Cambridge | Mikrochip-arzneistoffverabreichungssysteme und herstellungsverfahren |
| US6988983B2 (en) * | 2000-04-14 | 2006-01-24 | Solace Therapeutics, Inc. | Implantable self-inflating attenuation device |
| US6682473B1 (en) * | 2000-04-14 | 2004-01-27 | Solace Therapeutics, Inc. | Devices and methods for attenuation of pressure waves in the body |
| US6749553B2 (en) * | 2000-05-18 | 2004-06-15 | Theragenics Corporation | Radiation delivery devices and methods for their manufacture |
| US6398718B1 (en) * | 2000-06-15 | 2002-06-04 | Innoventions, Inc. | Intravesicular device |
| WO2003020210A2 (en) * | 2001-08-29 | 2003-03-13 | Umd, Inc. | Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| AU2002341959A1 (en) * | 2001-10-04 | 2003-04-14 | Case Western Reserve University | Drug delivery devices and methods |
| US8685427B2 (en) | 2002-07-31 | 2014-04-01 | Boston Scientific Scimed, Inc. | Controlled drug delivery |
| GB2385273B (en) * | 2002-02-13 | 2004-05-26 | Deborah Huang | Drug delivery device |
| US6949125B2 (en) | 2002-04-16 | 2005-09-27 | Boston Scientific Scimed, Inc. | Ureteral stent with end-effector and related methods |
| GB0211286D0 (en) | 2002-05-16 | 2002-06-26 | Nokia Corp | Routing data packets through a wireless network |
| DE10247689A1 (de) * | 2002-10-12 | 2004-04-22 | Martin Rahe | Implantat in der Harnblase |
| CA2503193A1 (en) * | 2002-10-22 | 2004-05-06 | The Biomerix Corporation | Method and system for intravesicular delivery of therapeutic agents |
| US9440302B2 (en) | 2002-12-16 | 2016-09-13 | The Regents Of The University Of Michigan | Assembly and planar structure for use therein which is expandable into a 3-D structure such as a stent and device for making the planar structure |
| US20050228482A1 (en) * | 2003-09-26 | 2005-10-13 | William Herzog | Stent covered by a layer having a layer opening |
| JP2007521914A (ja) | 2004-02-11 | 2007-08-09 | エシコン・インコーポレイテッド | 超小型電子機械システムを用いた尿力学評価方法および評価システム |
| US7862552B2 (en) * | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| EP1933810B1 (en) | 2005-08-11 | 2012-10-10 | Massachusetts Institute of Technology | Intravesical drug delivery device and method |
| US20070255222A1 (en) | 2006-03-27 | 2007-11-01 | Changqing Li | Catheter assembly including internal bolster |
| CA2661191C (en) | 2006-08-23 | 2014-12-02 | Svip 2 Llc | Devices and methods for altering eating behavior |
| US20100076261A1 (en) * | 2006-09-28 | 2010-03-25 | Medvision Inc. | Examination device |
| US8128576B2 (en) | 2006-12-07 | 2012-03-06 | Ethicon, Inc. | System and method for urodynamic evaluation utilizing micro electro-mechanical system technology |
| AU2008335077B2 (en) * | 2007-12-11 | 2014-05-29 | Massachusetts Institute Of Technology | Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens |
| EP2257250A2 (en) * | 2008-01-29 | 2010-12-08 | Gilbert H. Kliman | Drug delivery devices, kits and methods therefor |
| KR101689786B1 (ko) * | 2008-08-09 | 2016-12-26 | 메사츄세츠 인스티튜트 어브 테크놀로지 | 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치 |
| US20100048266A1 (en) | 2008-08-19 | 2010-02-25 | Samsung Electronics Co., Ltd. | Antenna device |
| US8343516B2 (en) * | 2009-06-26 | 2013-01-01 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| CA2784601C (en) * | 2009-12-17 | 2016-06-14 | Taris Biomedical, Inc. | Implantable device with intravesical tolerability and methods of treatment |
-
2010
- 2010-12-17 CA CA2784601A patent/CA2784601C/en active Active
- 2010-12-17 PL PL21157457.9T patent/PL3884988T3/pl unknown
- 2010-12-17 AU AU2010339821A patent/AU2010339821B2/en active Active
- 2010-12-17 LT LTEP21157457.9T patent/LT3884988T/lt unknown
- 2010-12-17 SI SI201032160T patent/SI3884988T1/sl unknown
- 2010-12-17 WO PCT/US2010/061161 patent/WO2011084712A1/en not_active Ceased
- 2010-12-17 RS RS20250812A patent/RS67130B1/sr unknown
- 2010-12-17 FI FIEP21157457.9T patent/FI3884988T3/fi active
- 2010-12-17 HR HRP20210329TT patent/HRP20210329T1/hr unknown
- 2010-12-17 EP EP10801519.9A patent/EP2512581B1/en active Active
- 2010-12-17 HR HRP20250946TT patent/HRP20250946T1/hr unknown
- 2010-12-17 SM SM20250293T patent/SMT202500293T1/it unknown
- 2010-12-17 PT PT211574579T patent/PT3884988T/pt unknown
- 2010-12-17 HU HUE10801519A patent/HUE053888T2/hu unknown
- 2010-12-17 JP JP2012544930A patent/JP2013514837A/ja active Pending
- 2010-12-17 DK DK10801519.9T patent/DK2512581T3/da active
- 2010-12-17 ES ES21157457T patent/ES3038403T3/es active Active
- 2010-12-17 PL PL10801519T patent/PL2512581T3/pl unknown
- 2010-12-17 LT LTEP10801519.9T patent/LT2512581T/lt unknown
- 2010-12-17 US US12/972,364 patent/US8679094B2/en active Active
- 2010-12-17 RS RS20210244A patent/RS61980B1/sr unknown
- 2010-12-17 EP EP21157457.9A patent/EP3884988B1/en active Active
- 2010-12-17 DK DK21157457.9T patent/DK3884988T3/da active
- 2010-12-17 SI SI201032058T patent/SI2512581T1/sl unknown
- 2010-12-17 SM SM20210236T patent/SMT202100236T1/it unknown
- 2010-12-17 ES ES10801519T patent/ES2867399T3/es active Active
- 2010-12-17 PT PT108015199T patent/PT2512581T/pt unknown
-
2014
- 2014-03-25 US US14/224,256 patent/US11065426B2/en active Active
-
2015
- 2015-10-26 JP JP2015209758A patent/JP6247270B2/ja active Active
-
2017
- 2017-07-31 JP JP2017147685A patent/JP6854210B2/ja active Active
-
2021
- 2021-04-28 CY CY20211100370T patent/CY1124354T1/el unknown
- 2021-05-04 US US17/307,082 patent/US11890439B2/en active Active
-
2024
- 2024-01-19 US US18/417,811 patent/US20240198067A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124354T1 (el) | Εμφυτευσιμη συσκευη με ενδοκυστικη ανεκτικοτητα | |
| CY1124556T1 (el) | Εμφυτευσιμη συσκευη για εσωτερικο ελεγχο της ουρησης | |
| ES2580132T3 (es) | Órtesis de estimulación | |
| CY1124658T1 (el) | Συσκευη για τη θεραπευτικη αντιμετωπιση της παχυσαρκιας | |
| MX2010005271A (es) | Miembro de soporte de tejido ajustable. | |
| ATE496652T1 (de) | Implantierbare medizinische leitung | |
| CY1124890T1 (el) | Συστηματα και μεθοδοι χορηγησης φαρμακων για θεραπεια καρκινου της ουροδοχου κυστης που περιλαμβανουν οξαλιπλατινη | |
| MY198078A (en) | Medical device | |
| ITFI20020145A1 (it) | Dispositivo per il trattamento chirurgico del prolasso femminile. | |
| AR063619A1 (es) | Dispositivos y metodos para la administraicion de un farmaco oftalmico | |
| EA033368B1 (ru) | Устройство для управления потоком в органе тела | |
| BRPI0712194A2 (pt) | Implantes pélvico e cirúrgico combinação ferramenta cirúrgica útil para implantar um implante pélvico métodos de tratamento de uma condição pélvica, e de prolapso vaginal, e, método para manipular um implante cirúrgico | |
| DE602004029159D1 (enExample) | ||
| WO2013098644A3 (en) | Implantable medical device housing and anchoring | |
| ATE416798T1 (de) | Medizinprodukt mit gewebeabhängiger arzneimittelelution | |
| BR112018070726A2 (pt) | dispositivo espaçador para tratamento de uma junta do corpo humano | |
| AR048645A1 (es) | Tratamientos para el implante ocular de efecto terapeutico prolongado | |
| BRPI0820800A2 (pt) | Dispositivo médico implantável para liberação controlada de droga, e, métodos para administração de uma droga na bexiga de um paciente e para tratar a bexiga em um paciente | |
| WO2015200752A8 (en) | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems | |
| WO2021035222A3 (en) | Apparatus for systemic human enhancement from administration of frequency therapy including enhanced stem cell and genetic therapy | |
| WO2014210315A3 (en) | Stents and methods of use thereof | |
| MX2018002645A (es) | Dispositivo de implantacion de pildora y kit de herramientas. | |
| EP3590338A3 (en) | Medical treatments based on anamorelin | |
| EP4349277A3 (en) | Device for tissue repair | |
| EP4335490A3 (en) | Implantable intra- and trans- body wireless networks for therapies |